Farmakeio Outsourcing recalls
Farmakeio Outsourcing has 15 recalls on record with the FDA and USDA, the earliest in 2025 and the latest reported on 5 Nov 2025. 15 are still ongoing. 15 were reported in the last 12 months. The most frequent reason is particulate matter.
Total recalls15since 2025
Last 12 months15reported
Class I00% of total
Ongoing15latest 5 Nov 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 15 100%Class III 0 0%
Why farmakeio outsourcing is recalled
Product types
By year
Ongoing farmakeio outsourcing recalls
15 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Testosterone 5 MG, 1 Pellet (Sterile) For Subcutaneous Insertion recalled | Farmakeio Outsourcing | Particulate Matter | Nationwide |
| Drug | CLASS II | Testosterone Regular Release 200 MG, 1 Pellet recalled | Farmakeio Outsourcing | Particulate Matter | Nationwide |
| Drug | CLASS II | Testosterone / Triamcinolone Acetonide, 5MG/12.5MCG recalled | Farmakeio Outsourcing | Particulate Matter | Nationwide |
| Drug | CLASS II | Testosterone 200 MG, 1 Pellet (Sterile) For Subcutaneous Insertion recalled | Farmakeio Outsourcing | Particulate Matter | Nationwide |
| Drug | CLASS II | Testosterone / Triamcinolone Acetonide 50MG/10MCG, 1 Pellet recalled | Farmakeio Outsourcing | Particulate Matter | Nationwide |
| Drug | CLASS II | Testosterone Regular Release 50 MG, 1 Pellet recalled | Farmakeio Outsourcing | Particulate Matter | Nationwide |
All farmakeio outsourcing recalls, newest first
15 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.